Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

Abstract

Reliable delivery of a diagnostic assay able to screen for a range of actionable mutations in this cohort was achieved, opening unexpected avenues for investigation and treatment of cancer patients.